Wheat values open 2023 down in Brazil
The scenario is linked to the high availability of the cereal after the record harvest in the country, which ended in December
More than R$400 million invested, in Brazil alone. This was the budget allocated to R&D programs by GDM - a multinational in plant genetic improvement.
The commitment allowed the launch of the first two non-GMO soybeans (Genetically Modified Organisms), created in Brazil, for the South American market.
The first, approved in March in the country, has a low presence of raffinose and stachyose sugars, with the aim of increasing nutritional quality, allowing farmers to spend less on fattening and faster weight gain in animals. This variety was also approved in Argentina, in September, and has just been approved - on December 9th - by Colombia.
The second edited soybean, developed for drought tolerance, was approved for conventional planting in Brazil in May; and, in November, in Argentina.
Humans and other monogastric animals do not have enzymes to break down raffinose and stachyose in the stomach and small intestine. They end up fermented by bacteria in the large intestine, which generates carbon dioxide and methane. Result: the process causes flatulence.
The Spanish Genetica de Soja Holding, S.L. (LAW 959800PXPG6GTKE4KH91) controls the Uruguayan GDM Holding SA (LAW 549300UKP1L7CCXVC770), which controls GDM HOLDING BRASIL, which controls GDM GENETICA DO BRASIL. The companies also control Seedcorp HO.
Receive the latest agriculture news by email
Receive the latest agriculture news by email